ST Biosciences logo — A global biotech company, involved in the R&D, cultivation,...

ST Biosciences

A global biotech company, involved in the R&D, cultivation, processing and commercialization of cannabis products.

Founded 2012 United States New York, United States 51-200 employees Biotechnology

General Information

Company Name ST Biosciences
Founded Year 2012
Location United States New York, United States +1
Employees 51-200
Industries Biotechnology
Social

Get notified when ST Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ST Biosciences

ST Biosciences is a global biotech company that specializes in the research, development, cultivation, processing, and commercialization of pharmaceutical and medicinal cannabis products. The company prides itself on setting the global standard in Cannabis Life Science through the creation of innovative cannabis-based pharmaceutical, nutraceutical, and medicinal products, as well as the establishment of state-of-the-art cannabis cultivation facilities. Founded in 2012, ST Biosciences has made its mark in 31 markets worldwide, including the U.S., South America, Europe, and Asia. As a fully vertical company, ST Biosciences controls the entire product life cycle chain, from genetics development to distribution, maintaining the highest industry standards with facilities that meet GMP, GAP, and ISO certification. This approach ensures consistent product quality and grants the company a significant advantage in the global marketplace. With a firm belief in the transformative power of CBD and TJC, ST Biosciences is uniquely positioned to leverage its expertise and global presence to deliver on its promises.

Taxonomy: Phytopharmaceuticals, Cannabis-based Pharmaceuticals, Medicinal Cannabis Products, CBD, TJC, Vertical Integration, Global Expansion, Cultivation Facilities, GMP Certification, Research and Development, Drug Discovery, Psilocybin Molecules, Nutraceuticals

No funding data available for ST Biosciences yet.

Get notified when ST Biosciences raises funding

ST Biosciences Alternatives & Competitors

ST Biosciences vs

Unlocking the potential of cannabinoids to develop innovative pharmaceuticals and consumer health pr...

Convertible Note
113 employees
Biotechnology, Health Care
ST Biosciences vs

Discover premium medicinal cannabis solutions for a healthier, happier future.

Agriculture, Health Care
ST Biosciences vs

Botanical Holdings invests in all aspects of legal medicinal cannabis and has a growing portfolio wo...

Grant

FAQ About ST Biosciences

A global biotech company, involved in the R&D, cultivation, processing and commercialization of cannabis products.
ST Biosciences was founded in 2012.
ST Biosciences is headquartered in New York, United States.
ST Biosciences operates in the following industries: Biotechnology.
ST Biosciences has approximately 51-200 employees.
Top alternatives and competitors to ST Biosciences include Sanity Group, BBS Pharmaceuticals, Botanical Holdings, SafriCanna, Linneo Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ST Biosciences and Sanity Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ST Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy